About: Assessment of Total Cardiovascular Risk in Hypertension: The Role of Subclinical Organ Damage

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Assessment of Total Cardiovascular Risk in Hypertension: The Role of Subclinical Organ Damage Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	The estimation of total cardiovascular risk is essential for guiding the management of hypertension. Computerized methods have been developed for estimating total cardiovascular risk (i.e., the likelihood of developing a cardiovascular event, usually within the ensuing 10 years), most of which are based either on the Framingham risk score or the European Systemic Coronary Risk Evaluation project. The 2007 European Society of Hypertension–European Society of Cardiology guidelines suggest subclinical organ damage as an integral part of the risk stratification and evaluation of hypertensive patients. Subclinical organ damage is considered an intermediate stage in the continuum of vascular disease and a determinant of overall cardiovascular risk. The search for subclinical organ damage should be performed carefully using the appropriate techniques depending on the availability and resources. Electrocardiography and evaluation of urinary albumin excretion should be part of the routine assessment of hypertensive patients. Subclinical organ damage should be also measured during treatment because there is evidence that regression of left ventricular hypertrophy and reduction of proteinuria are associated with improved prognosis. The search for subclinical organ damage should be made simultaneously in various organs because multiorgan subclinical organ damage is associated with a worse prognosis.). The estimation of total cardiovascular risk is essential for guiding the management of hypertension. Computerized methods have been developed for estimating total cardiovascular risk (i.e., the likelihood of developing a cardiovascular event, usually within the ensuing 10 years), most of which are based either on the Framingham risk score or the European Systemic Coronary Risk Evaluation project. The 2007 European Society of Hypertension–European Society of Cardiology guidelines suggest subclinical organ damage as an integral part of the risk stratification and evaluation of hypertensive patients. Subclinical organ damage is considered an intermediate stage in the continuum of vascular disease and a determinant of overall cardiovascular risk. The search for subclinical organ damage should be performed carefully using the appropriate techniques depending on the availability and resources. Electrocardiography and evaluation of urinary albumin excretion should be part of the routine assessment of hypertensive patients. Subclinical organ damage should be also measured during treatment because there is evidence that regression of left ventricular hypertrophy and reduction of proteinuria are associated with improved prognosis. The search for subclinical organ damage should be made simultaneously in various organs because multiorgan subclinical organ damage is associated with a worse prognosis.). (en)
Title	Assessment of Total Cardiovascular Risk in Hypertension: The Role of Subclinical Organ Damage Assessment of Total Cardiovascular Risk in Hypertension: The Role of Subclinical Organ Damage (en)
skos:prefLabel	Assessment of Total Cardiovascular Risk in Hypertension: The Role of Subclinical Organ Damage Assessment of Total Cardiovascular Risk in Hypertension: The Role of Subclinical Organ Damage (en)
skos:notation	RIV/00064190:_____/12:#0000436!RIV13-MZ0-00064190
http://linked.open...avai/riv/aktivita	V
http://linked.open...avai/riv/aktivity	V
http://linked.open...vai/riv/dodaniDat	2013
http://linked.open...aciTvurceVysledku	Cífková, Renata
http://linked.open.../riv/druhVysledku	C - Kapitola v knize
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Thomayerova nemocnice
http://linked.open...dnocenehoVysledku	123880
http://linked.open...ai/riv/idVysledku	RIV/00064190:_____/12:#0000436
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	Microalbuminuria; Reduced renal function; Left ventricular hypertrophy; Intima-media thickness; Pulse wave velocity (en)
http://linked.open.../riv/klicoveSlovo	Left ventricular hypertrophy Intima-media thickness Microalbuminuria Pulse wave velocity Reduced renal function
http://linked.open...ontrolniKodProRIV	[EA2F92792D30]
http://linked.open...i/riv/mistoVydani	Italia
http://linked.open...i/riv/nazevZdroje	Special Issues in Hypertension
http://linked.open...in/vavai/riv/obor	FA
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...v/pocetStranKnihy	483 (xsd:int)
http://linked.open...cetTvurcuVysledku	1 (xsd:int)
http://linked.open...UplatneniVysledku	2012
http://linked.open...iv/tvurceVysledku	Cífková, Renata
number of pages	13 (xsd:int)
http://bibframe.org/vocab/doi	10.1007/978-88-470-2601-8
http://purl.org/ne...btex#hasPublisher	Springer Milan
https://schema.org/isbn	978-88-470-2600-1

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 75 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software